Reporting Person: John Gillard
Issuer: TRINITY BIOTECH PLC
ADDITIONAL HOLDINGS EXHIBIT – CONTINUATION OF TABLE II
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) |
|||||||
|
1. Title of Derivative Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
||
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
||||
|
ADS OPTIONS
|
10/1/2026
|
12/19/2030
|
ADS OPTIONS
|
29,167
|
$2.40
|
DIRECT
|
N/A
|